Germany
Industry
Germany's largest health insurance fund Allgemeine Ortskrankenkasse (AOK) has initiated the first Europe-wide tenders for contracts to supply generic drugs, in an effort to spark...
2008-08-12Industry
Bayer Healthcare's oral anticoagulant, Xarelto (rivaroxaban), has been recommended for EU marketing authorisation by the European Medicine Agency (EMEA)'s Committee for Products for...
2008-07-28Industry
Strong growth in Central and Eastern Europe (CEE) for Sandoz, Novartis' generics division, has made a significant contribution to the generics company's H108 results. In US dollar...
2008-07-24Industry
Germany's drug discount contracts - which enforce pharmacists to dispense drugs for which health insurers have arranged price reductions with pharmaceutical companies - appear to...
2008-07-21Companies
Not wanting to be left behind in the current spate of biotech acquisitions, UK based Shire has struck a deal to acquire German firm Jerini for EUR349mn (US$548mn). In what Jerini...
2008-07-04Industry
BMI believes there is significant global growth potential for third party active pharmaceutical ingredient (API) inspection firms over the next few years. This is in light of the...
2008-06-12Industry
Switzerland-based drugmaker Nycomed is planning to sell part of its oncology pipeline to German firm 4SC in order to focus on developing drugs in its current areas of speciality....
2008-06-06Industry
Pharmaceutical wholesaler Phoenix Pharma France is to acquire fellow French player CERP Lorraine Répartition. The terms of the deal have not been
2008-06-04
